Ionis Pharmaceuticals shares are trading higher after Jefferies upgraded the stock from Underperform to Buy.
Portfolio Pulse from Benzinga Newsdesk
Ionis Pharmaceuticals shares are trading higher after Jefferies upgraded the stock from Underperform to Buy.
July 16, 2024 | 1:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ionis Pharmaceuticals shares are trading higher after Jefferies upgraded the stock from Underperform to Buy.
The upgrade from Jefferies is a significant positive signal for investors, likely leading to increased buying interest and a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100